腺病毒载体用于遗传性疾病的基因治疗
Anna Muravyeva1, Svetlana Smirnikhina1
1Laboratory of Genome Editing, Research Centre for Medical Genetics, Moskvorechye, 1, 115522 Moscow, Russia.
Biology
|January 8, 2025
概括
腺病毒载体对基因疗法有希望,但在遗传性疾病中面临挑战. 研究重点是修改这些载体以克服免疫反应并改善向传递以获得更好的治疗结果.
科学领域:
- 生物技术是生物技术.
- 基因治疗 基因治疗
- 病毒学 病毒学
背景情况:
- 腺病毒载体 (AdVs) 具有有利的特征,如广泛的热带性,高容量和高效的转导.
- 它们的实用性已在型病毒疗法和疫苗开发中得到证实.
- 尽管有效,但AdVs尚未成功实施用于治疗遗传性疾病.
研究的目的:
- 审查腺病毒载体 (AdVs) 和它们的特征.
- 分析基因替代疗法对单基因疾病的AdVs的临床试验,并确定失败的原因.
- 讨论当前的AdV修改策略,以减少免疫性和增强有针对性的交付.
主要方法:
- 关于腺病毒载体应用的文献综述.
- 对单基因疾病中基因替代疗法的临床试验数据的分析.
- 审查当前关于腺病毒载体修饰的研究.
主要成果:
- 腺病毒载体是强大的工具,但在治疗遗传疾病方面存在局限性.
- 使用AdVs治疗遗传性疾病的临床试验遇到了重大挑战.
- 免疫性和非目标分娩是导致治疗失败的关键因素.
结论:
- 腺病毒载体需要显著的修改才能适用于治疗遗传性疾病.
- 减轻免疫反应和改善载体向的策略对于未来的成功至关重要.
- 对腺病毒载体工程的进一步研究对于促进单基因疾病的基因疗法至关重要.
相关概念视频
Gene Therapy
25.2K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.2K
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.


